跳至主要内容
临床试验/NCT07733440
NCT07733440尚未招募不适用

Clinical Risk Calculator Validation and Implementation to Optimize Prostate Cancer Early Detection in Nigeria

Ahmadu Bello University1 个研究点 分布在 1 个国家目标入组 89 人开始时间: 2029年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
89
试验地点
1
主要终点
Task completion rate

研究概览

简要总结

This study is a pilot trial that builds on findings from the validation of prostate cancer risk calculators in Nigerian men. The goal of the overall study is to improve the early detection of prostate cancer in a high-risk population.

The main questions the validation study aims to answer are:

  1. How accurately do existing prostate cancer risk calculators identify Nigerian men with clinically significant prostate cancer?
  2. Will a new risk calculator designed for Nigerian men more accurately identify those with clinically significant prostate cancer?

The main questions the intervention study aims to answer is:

Will the primary care provider-facing risk calculator be feasible and acceptable for primary care providers to implement?

The intervention trial will be piloted among participants in community-level hospitals in order to primarily assess implementation outcomes

详细描述

The validation study will use prospective data from 500 participants with suspicion of prostate cancer to compare the effectiveness of prostate cancer risk calculator(s).

The intervention study is the only specific aim that meets the definition of a Clinical Trial. This clinicaltrial.gov information is based on the intervention study.

  1. For training, healthcare practitioners from community-level hospitals will be invited to participate. Before the training, a pre-test questionnaire will be given to conveniently sampled attending participants. After the training, the same questionnaire will be given to the same participants. The pre- and post-training knowledge scores will be compared to see if there is a change in knowledge.
  2. Supported risk assessment with the risk calculator will be piloted for at least six months. Primary care providers at community-level hospitals will use the online risk calculator to assess prostate cancer risk in patient participants 40-79 years old who are accessing their services. After the risk assessment, we will evaluate feasibility and acceptability using a mixed methods approach.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Training - Eligible primary care providers (for the training surveys) will be healthcare practitioners at community-level hospitals.
  • Supported Risk Assessment
  • (i) Eligible key informants will be eligible primary care providers who were trained and implemented the supported risk assessment and the targeted population of patient participants who received the supported risk assessment.
  • (ii) Eligible patient participants (for the collection of observation data) will be the target population of adult males 40 - 79 years accessing provider services.

排除标准

  • 未提供

结局指标

主要结局

Task completion rate

时间窗: 6 months

The percentage of risk calculator tasks successfully completed by providers during the risk assessment of patient participants. A task will be be considered successfully completed if all required steps are performed. Task completion will be documented using a standardized activity checklist and summarized using descriptive statistics.

Perceived feasibility of risk calculator use

时间窗: 6 months

Feasibility will be assessed through participants' perceptions of the suitability of the risk calculator for its intended clinical purpose and its fit within routine clinical workflow. Data will be collected through qualitative feedback interviews and analyzed using thematic analysis.

次要结局

  • Acceptability of risk calculator use(6 months)
  • Change in knowledge score following training(3 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Musliu Adetola Tolani

Senior Lecturer

Ahmadu Bello University

研究点 (1)

Loading locations...

相似试验